<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We studied the prevalence of various types of progressive <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (PMD) in Okinawa, Japan on December 31, 1989 and the incidence of Duchenne <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (DMD) in 5-year periods from 1957 to 1985 </plain></SENT>
<SENT sid="1" pm="."><plain>We classified patients with PMD clinically, electrophysiologically, molecular biologically and immunohistochemically with antidystrophin antibody, especially for <z:hpo ids='HP_0003745'>sporadic</z:hpo> cases of DMD, Becker <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (BMD) and <z:hpo ids='HP_0006785'>limb-girdle muscular dystrophy</z:hpo> (LG) </plain></SENT>
<SENT sid="2" pm="."><plain>The prevalence for <z:hpo ids='HP_0000001'>all</z:hpo> PMD in Okinawa was 7.13 X 10(-5) for DMD, 1.82 X 10(-5) for BMD in the male population, 1.55 X 10(-5) for LG, 1.14 X 10(-5) for <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo>, 2.03 X 10(-5) for facioscapulohumeral <z:hpo ids='HP_0003560'>muscular dystrophy</z:hpo> (FSH), and 9.13 X 10(-5) for myotonic <z:mpath ids='MPATH_554'>dystrophy</z:mpath> (MD) in the total population </plain></SENT>
<SENT sid="3" pm="."><plain>The incidence of DMD in the period 1957-1985 was 15.41 X 10(-5) live-born males (LBM) and 3.21 X 10(-5) LBM for BMD </plain></SENT>
<SENT sid="4" pm="."><plain>The incidence has apparently declined in Okinawa since 1975 </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of BMD, FSH and MD was rather high in Okinawa compared with previous reports </plain></SENT>
<SENT sid="6" pm="."><plain>Molecular biological techniques for classifying patients were indispensable for the epidemiological study of PMD </plain></SENT>
</text></document>